PTEN and prostate carcinoma: Cellular senescence is an irreversible growth arrest process mainly controlled by p53, p21, and p16ink4a proteins [17], and as reported for prostate cancer [18], PTEN loss can trigger cellular senescence both in vitro and in vivo.